Growth Opportunity Small, focused medical device company with a flagship infection-control product (CleanCision) that is early in market with recent Series B funding and board expansion. Target this round as potential co-development, pilot programs, and strategic partnerships with hospitals seeking advanced infection control solutions.

Hospital Partnerships Active collaboration with hospitals on best practices and a device designed to integrate into operative workflows. Leverage ongoing partnerships to propose additional trainings, deployment across new ORs, and expansion into adjacent facilities within networks.

Clinical Validation Recognized finalist at Medical Design Excellence Awards and emphasis on Human Factors testing to minimize use errors. Position as a customer-reduced risk solution with case studies, surgeon endorsements, and demonstrated post-operative outcome improvements to drive procurement discussions.

Strategic Investors Recent $10M Series B led by Baxter Ventures indicates strategic investor interest and potential for co-selling, integration with Baxter’s product ecosystem, or leverage of their distribution channels for broader market access.

Tech & Adoption Leverages a modern tech stack and digital presence (WordPress, MySQL, HTTP/3) for marketing and education; opportunities exist to enhance digital funnel, targeted campaigns, and virtual demos to accelerate awareness and trial among hospitals evaluating infection-control devices.